Summarizing, the sensitivity of ovarian cancer cells to chemotherapeutic drugs involves p53 phosphorylation via OPA1 processing or by DRP1ser637 dephosphorylation [28], both leading to mitochondrial fragmentation [123,124,125,126]. Here, OPA1 is linked to ovarian carcinoma.